Molecular characterization of Streptococcus pyogenes (StrepA) non-invasive isolates during the 2022–2023 UK upsurge

Abstract excerpt

At the end of 2022 into early 2023, the UK Health Security Agency reported unusually high levels of scarlet fever and invasive disease caused by Streptococcus pyogenes (StrepA or group A Streptococcus). During this time, we collected and genome-sequenced 341 non-invasive throat and skin S. pyogenes isolates identified during routine clinical diagnostic testing in Sheffield, a large UK city. We compared the data...

Topics

Join the communities discussing this publication.

• Bacterial Identification and Susceptibility Testing
• Infective Endocarditis Diagnosis and Management
• Streptococcal Infections and Treatments